Dr. Reddy's Laboratories Limited (BOM:500124)
1,195.35
+38.95 (3.37%)
At close: May 12, 2025
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 |
Global Generics | 245.45B |
Log In |
Log In |
Log In |
Log In |
Global Generics Growth | 14.82% |
Log In |
Log In |
Log In |
Log In |
Pharmaceutical Services and Active Ingredients | 29.80B |
Log In |
Log In |
Log In |
Log In |
Pharmaceutical Services and Active Ingredients Growth | 2.52% |
Log In |
Log In |
Log In |
Log In |
Other | 3.91B |
Log In |
Log In |
Log In |
Log In |
Other Growth | 28.53% |
Log In |
Log In |
Log In |
Log In |
Proprietary Products | - |
Log In |
Log In |
Log In |
Log In |
Proprietary Products Growth | - |
Log In |
Log In |
Log In |
Log In |
Other | 3.91B |
Log In |
Log In |
Log In |
Log In |
Other Growth | 28.53% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 |
Other | 72.83B |
Log In |
Log In |
Log In |
Log In |
Other Growth | 7.94% |
Log In |
Log In |
Log In |
Log In |
United States | 135.57B |
Log In |
Log In |
Log In |
Log In |
United States Growth | 27.07% |
Log In |
Log In |
Log In |
Log In |
India | 48.47B |
Log In |
Log In |
Log In |
Log In |
India Growth | -4.01% |
Log In |
Log In |
Log In |
Log In |
Russia | 22.30B |
Log In |
Log In |
Log In |
Log In |
Russia Growth | 5.05% |
Log In |
Log In |
Log In |
Log In |
Other | 72.83B |
Log In |
Log In |
Log In |
Log In |
Other Growth | 7.94% |
Log In |
Log In |
Log In |
Log In |